{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:29Z","timestamp":1792684649353,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hoc.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:22:52Z","timestamp":1780957372000},"page":"451-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiological Assessment of Liver and Biliary Neoplasms"],"prefix":"10.1016","volume":"40","author":[{"given":"Rayane","family":"El Rahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Taouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib4","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"10360","key":"10.1016\/j.hoc.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000453013","article-title":"Epidemiology and risk factors of cholangiocarcinoma","volume":"32","author":"Kirstein","year":"2016","journal-title":"Visc Med"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2468-1253(23)00111-5","article-title":"Fibroblasts in liver cancer: functions and therapeutic translation","volume":"8","author":"Affo","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2025.0042","article-title":"Biliary tract cancers, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Benson","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5S","key":"10.1016\/j.hoc.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jacr.2019.02.012","article-title":"ACR appropriateness Criteria((R)) jaundice","volume":"16","author":"Hindman","year":"2019","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"10272","key":"10.1016\/j.hoc.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11S","key":"10.1016\/j.hoc.2026.05.002_bib16","first-page":"S699","article-title":"ACR appropriateness Criteria(R) staging and Follow-Up of primary liver cancer","volume":"22","author":"Expert Panel on Gastrointestinal","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00261-024-04305-9","article-title":"Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT\/MRI in patients at risk for HCC","volume":"49","author":"Kono","year":"2024","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00261-017-1250-0","article-title":"Ceus LI-RADS: algorithm, implementation, and key differences from CT\/MRI","volume":"43","author":"Wilson","year":"2018","journal-title":"Abdom Radiol"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.rcl.2022.05.001","article-title":"Update on biliary cancer imaging","volume":"60","author":"Kim","year":"2022","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.23071","article-title":"Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma","volume":"50","author":"Rimola","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1148\/radiology.203.1.9122423","article-title":"Cholangiocarcinoma: delayed CT contrast enhancement patterns","volume":"203","author":"Lacomis","year":"1997","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hep.29487","article-title":"Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"67","author":"Roberts","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib24","first-page":"22","article-title":"Contrast agents used in MR imaging of the liver","volume":"12","author":"Karabulut","year":"2006","journal-title":"Diagn Interv Radiol"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.002_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133393","article-title":"Contrast-enhanced imaging in the management of intrahepatic cholangiocarcinoma: state of art and future perspectives","volume":"15","author":"Cerrito","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13651820701504207","article-title":"Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study","volume":"9","author":"Saluja","year":"2007","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2967\/jnumed.108.055087","article-title":"A prospective evaluation of 18F-FDG and 11C-acetate PET\/CT for detection of primary and metastatic hepatocellular carcinoma","volume":"49","author":"Park","year":"2008","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1007\/s00330-025-11352-3","article-title":"Prognostic and diagnostic value of [(18)F]FDG, (11)C-acetate, and [(68)Ga]Ga-FAPI-04 PET\/CT for hepatocellular carcinoma","volume":"35","author":"Xu","year":"2025","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2006.01335.x","article-title":"Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma","volume":"26","author":"Li","year":"2006","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/lt.25743","article-title":"Addition of [(18) F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross-Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma","volume":"26","author":"John","year":"2020","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib31","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i5.105446","article-title":"Progress in the application of fludeoxyglucose positron emission tomography computed tomography in biliary tract cancer","volume":"17","author":"Yin","year":"2025","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhep.2019.01.038","article-title":"(18)F-fluorodeoxyglucose positron emission tomography ((18)FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis","volume":"71","author":"Lamarca","year":"2019","journal-title":"J Hepatol"},{"issue":"35","key":"10.1016\/j.hoc.2026.05.002_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020932","article-title":"Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: a meta-analysis","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.hoc.2026.05.002_bib34","article-title":"Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response","volume":"6","author":"Osho","year":"2020","journal-title":"Hepatoma Res"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib35","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in At-Risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2018.11.020","article-title":"Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall Malignancy-A systematic review","volume":"156","author":"van der Pol","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/liv.14424","article-title":"Diagnostic performance of CT\/MRI liver imaging reporting and data system v2017 for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib38","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220646","article-title":"Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.002_bib39","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1007\/s00330-021-07815-y","article-title":"Inter-reader reliability of CT liver imaging reporting and data system according to imaging analysis methodology: a systematic review and meta-analysis","volume":"31","author":"Kang","year":"2021","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jmri.27065","article-title":"Interreader agreement of liver imaging reporting and data system on MRI: a systematic review and meta-analysis","volume":"52","author":"Kang","year":"2020","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.hoc.2026.05.002_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejrad.2016.11.004","article-title":"Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm","volume":"86","author":"Becker","year":"2017","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1148\/radiol.14131963","article-title":"Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging","volume":"272","author":"Davenport","year":"2014","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00261-015-0623-5","article-title":"Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas","volume":"41","author":"Ehman","year":"2016","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiol.2017170376","article-title":"Interreader reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study","volume":"286","author":"Fowler","year":"2018","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib45","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222855","article-title":"A multicenter assessment of interreader reliability of LI-RADS version 2018 for MRI and CT","volume":"307","author":"Hong","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2026.05.002_bib46","series-title":"Hepatocellular carcinoma: translational precision medicine approaches","first-page":"27","article-title":"Hepatocellular carcinoma surveillance and staging","author":"Singal","year":"2019"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"Marrero","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the Barcelona clinic liver cancer staging system","volume":"44","author":"Cillo","year":"2006","journal-title":"J Hepatol"},{"issue":"3\u20134","key":"10.1016\/j.hoc.2026.05.002_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000343861","article-title":"Multimodality management for Barcelona clinic liver cancer stage C hepatocellular carcinoma","volume":"3","author":"Choi","year":"2014","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14218\/JCTH.2019.00050","article-title":"Liver transplantation beyond milan criteria","volume":"8","author":"Lingiah","year":"2020","journal-title":"J Clin Transl Hepatol"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.002_bib52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.hoc.2026.05.002_bib53","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1200\/JCO.2003.11.137","article-title":"The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time","volume":"21","author":"Yoo","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib54","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajpath.2024.08.014","article-title":"Morphomolecular pathology and genomic insights into the cells of origin of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma","volume":"195","author":"Guest","year":"2025","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.002_bib57","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s00261-024-04769-9","article-title":"Standardizing the reporting of cholangiocarcinoma: the society of abdominal radiology disease focused panel on cholangiocarinoma lexicon","volume":"50","author":"R","year":"2025","journal-title":"Abdom Radiol"},{"issue":"9935","key":"10.1016\/j.hoc.2026.05.002_bib58","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3348\/jksr.2024.0055","article-title":"Preoperative imaging assessment and staging of perihilar cholangiocarcinoma: tips and pitfalls","volume":"86","author":"Yong","year":"2025","journal-title":"J Korean Soc Radiol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02471576","article-title":"The general rules for the clinical and pathological study of primary liver cancer. Liver cancer study group of Japan","volume":"19","year":"1989","journal-title":"Jpn J Surg"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/rg.293085729","article-title":"Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation","volume":"29","author":"Chung","year":"2009","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","article-title":"Pathologic classification of cholangiocarcinoma: new concepts","volume":"29","author":"Nakanuma","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.002_bib63","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0046-8177(88)80156-4","article-title":"A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading","volume":"19","author":"Nakajima","year":"1988","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","article-title":"Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings","volume":"181","author":"Lim","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib65","doi-asserted-by":"crossref","first-page":"W64","DOI":"10.2214\/AJR.16.16923","article-title":"Cross-sectional imaging of intrahepatic cholangiocarcinoma: development, growth, spread, and prognosis","volume":"209","author":"Seo","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.002_bib66","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1046\/j.1365-2168.1998.00815.x","article-title":"Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment","volume":"85","author":"Sasaki","year":"1998","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib67","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2214\/ajr.176.6.1761499","article-title":"MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation","volume":"176","author":"Maetani","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiographics.22.1.g02ja15173","article-title":"Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings","volume":"22","author":"Han","year":"2002","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiol.12112308","article-title":"Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images","volume":"264","author":"Kang","year":"2012","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib70","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ejrad.2012.10.010","article-title":"Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI","volume":"82","author":"Peporte","year":"2013","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1478-3231.2011.02640.x","article-title":"MRI features of hepatocellular carcinoma expressing progenitor cell markers","volume":"32","author":"Jeong","year":"2012","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1148\/radiol.2018171187","article-title":"Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges","volume":"288","author":"Joo","year":"2018","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2214\/AJR.14.12830","article-title":"Imaging of perihilar cholangiocarcinoma","volume":"204","author":"Engelbrecht","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1711390210","article-title":"Pathological aspects of cholangiocarcinoma","volume":"139","author":"Weinbren","year":"1983","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clinimag.2007.08.022","article-title":"Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes","volume":"32","author":"Kim","year":"2008","journal-title":"Clin Imaging"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib76","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/radiol.2331031446","article-title":"Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP","volume":"233","author":"Park","year":"2004","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib78","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1148\/radiology.172.3.2549565","article-title":"Hilar cholangiocarcinoma: comparative study with sonography and CT","volume":"172","author":"Choi","year":"1989","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mge.2002.125363","article-title":"MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma","volume":"56","author":"Lee","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.002_bib80","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2214\/ajr.175.3.1750721","article-title":"CT features of intraductal intrahepatic cholangiocarcinoma","volume":"175","author":"Lee","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2002.3.1.57","article-title":"Radiological spectrum of intraductal papillary tumors of the bile ducts","volume":"3","author":"Lim","year":"2002","journal-title":"Korean J Radiol"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib82","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00261-013-9989-4","article-title":"Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI","volume":"38","author":"Yoon","year":"2013","journal-title":"Abdom Imaging"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5306\/wjco.v2.i2.94","article-title":"Surgical strategy for bile duct cancer: advances and current limitations","volume":"2","author":"Akamatsu","year":"2011","journal-title":"World J Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib84","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bpg.2015.02.004","article-title":"Radiological diagnosis in cholangiocarcinoma: application of computed tomography, magnetic resonance imaging, and positron emission tomography","volume":"29","author":"Ringe","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/13651820801992617","article-title":"Staging cholangiocarcinoma by imaging studies","volume":"10","author":"Vilgrain","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.002_bib86","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/hep4.1774","article-title":"Clinical staging of mass-forming intrahepatic cholangiocarcinoma: computed tomography versus magnetic resonance imaging","volume":"5","author":"Kim","year":"2021","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.002_bib87","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"1017","key":"10.1016\/j.hoc.2026.05.002_bib88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1259\/bjr\/88405305","article-title":"Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"85","author":"Ruys","year":"2012","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.002_bib89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib90","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","article-title":"Intrahepatic cholangiocarcinoma: macroscopic type and stage classification","volume":"10","author":"Yamasaki","year":"2003","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.002_bib92","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib93","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000530700","article-title":"Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management","volume":"13","author":"Ye","year":"2024","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00261-013-0069-6","article-title":"Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma","volume":"39","author":"Shetty","year":"2014","journal-title":"Abdom Imaging"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.002_bib95","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2214\/AJR.12.9488","article-title":"Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI","volume":"201","author":"Fowler","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.002_bib96","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3348\/kjr.2018.0636","article-title":"Atypical appearance of hepatocellular carcinoma and its mimickers: how to solve challenging cases using gadoxetic acid-enhanced liver magnetic resonance imaging","volume":"20","author":"Kim","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.hoc.2026.05.002_bib97","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejro.2014.07.001","article-title":"Current update on combined hepatocellular-cholangiocarcinoma","volume":"1","author":"Maximin","year":"2014","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.17998\/jlc.21.1.12","article-title":"Update on pathologic and radiologic diagnosis of combined hepatocellular-cholangiocarcinoma","volume":"21","author":"Rhee","year":"2021","journal-title":"J Liver Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib99","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00261-024-04476-5","article-title":"MRI features of combined hepatocellular-cholangiocarcinoma","volume":"50","author":"Majeed","year":"2025","journal-title":"Abdom Radiol"},{"issue":"35","key":"10.1016\/j.hoc.2026.05.002_bib100","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v27.i35.5978","article-title":"Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging","volume":"27","author":"Stollmayer","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12880-022-00946-8","article-title":"A comparative study between deep learning and radiomics models in grading liver tumors using hepatobiliary phase contrast-enhanced MR images","volume":"22","author":"Du","year":"2022","journal-title":"BMC Med Imag"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.002_bib102","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1007\/s00330-019-06205-9","article-title":"Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI","volume":"29","author":"Hamm","year":"2019","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.002_bib103","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1007\/s00330-020-07559-1","article-title":"Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver","volume":"31","author":"Oestmann","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hoc.2026.05.002_bib104","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2147\/JHC.S316385","article-title":"A semi-automatic step-by-step expert-guided LI-RADS grading system based on gadoxetic acid-enhanced MRI","volume":"8","author":"Sheng","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.002_bib105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00261-022-03679-y","article-title":"Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study","volume":"48","author":"Han","year":"2023","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.hoc.2026.05.002_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00680","article-title":"Deep learning for accurate diagnosis of liver tumor based on magnetic resonance imaging and clinical data","volume":"10","author":"Zhen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2026.05.002_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2022.100424","article-title":"Noninvasively predict the micro-vascular invasion and histopathological grade of hepatocellular carcinoma with CT-derived radiomics","volume":"9","author":"Tong","year":"2022","journal-title":"Eur J Radiol Open"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.002_bib108","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s00330-020-07250-5","article-title":"Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma","volume":"31","author":"Chu","year":"2021","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.002_bib109","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","article-title":"Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE","volume":"31","author":"Kong","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hoc.2026.05.002_bib110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmp.2021.02.013","article-title":"A deep survival interpretable radiomics model of hepatocellular carcinoma patients","volume":"82","author":"Wei","year":"2021","journal-title":"Phys Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:29:25Z","timestamp":1784579365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858826000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889858826000420"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiological Assessment of Liver and Biliary Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}